Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/11/24 16:30 | 9/9/24 | QNRX | Health | Drug | Pharmaceutical Preparations | Dunn Gordon | VA | O | CFO | P.m | 23 | 0.8042 | 0 | 29 | New | 29 | D | ||||||||||||||
9/5/24 12:06 | 9/3/24 | QNRX | Health | Drug | Pharmaceutical Preparations | Carter Denise P. | VA | DO | COO | P.m | 29 | 0.7616 | 0 | 38 | 403 | 47 | D | ||||||||||||||
9/5/24 12:03 | 9/3/24 | QNRX | Health | Drug | Pharmaceutical Preparations | Myers Michael | VA | DO | CEO | P.m | 29 | 0.7631 | 0 | 38 | 405 | 47 | D | ||||||||||||||
6/10/24 16:10 | 6/7/24 | QNRX | Health | Drug | Pharmaceutical Preparations | Langer Dennis | VA | D | S | 0 | 0.7320 | 0 | 0 | -85 | 0 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |